SecBot SecBot
SECBOTREPLAY Home › Report › RVMD

RVMD · Fidelity stake 7.2%

Revolution Medicines, Inc. · SC 13G/A filed Nov 5, 2026 at 13:24 ET

At the news

NEUTRALIMPACT 3/10

SC 13G/A filed Nov 5, 2026 at 13:24 ET

FMR LLC (Fidelity) filed an amended Schedule 13G disclosing a 7.2% passive stake in Revolution Medicines as of September 30, 2026, up from a prior filing. The increase reflects Fidelity's continued accumulation following the company's strong Q3 earnings beat from its newly approved drug RASONQUE.

  • FMR LLC (Fidelity) reported beneficial ownership of 15,402,102.97 shares of Revolution Medicines common stock as of September 30, 2026.
  • The stake represents 7.2% of shares outstanding.
  • This is an amendment to a prior Schedule 13G filing, indicating an increase from the previously reported position.
  • The filing is passive (Rule 13d-1(b)), with no intent to influence control.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access